Global Medical REIT Inc. - Common (GMRE) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2016 to Q4 2025

Type / Class
Equity / Common
Symbol
GMRE on NYSE
Shares outstanding
67,214,667
Price per share
$7.53
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
93,254
Total reported value
$877,015
% of total 13F portfolios
0%
Share change
-43,450,565
Value change
-$301,595,459
Number of holders
6
Price from insider filings
$7.53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Global Medical REIT Inc. - Common (GMRE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRUDENTIAL FINANCIAL INC 5.1% $26,292,361 3,427,948 PRUDENTIAL FINANCIAL INC 31 Mar 2025

As of 30 Sep 2025, 6 institutional investors reported holding 93,254 shares of Global Medical REIT Inc. - Common (GMRE). This represents 0.14% of the company’s total 67,214,667 outstanding shares.

Institutional Holders of Global Medical REIT Inc. - Common (GMRE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$880,945 $7.53 0
2025 Q3 93,254 $877,015 -$301,595,459 $21.17 6
2025 Q2 44,078,833 $305,915,272 -$7,355,021 $6.93 193
2025 Q1 44,919,385 $393,462,084 +$31,186,661 $8.75 203
2024 Q4 41,584,167 $321,473,041 +$3,617,908 $7.72 198
2024 Q3 40,651,775 $403,031,852 +$23,916,746 $9.91 197
2024 Q2 38,164,870 $347,156,911 -$1,839,879 $9.08 197
2024 Q1 37,353,503 $327,543,939 -$6,229,507 $8.75 202
2023 Q4 37,724,096 $419,205,355 +$14,600,796 $11.10 191
2023 Q3 36,486,504 $327,705,824 -$3,473,792 $8.97 182
2023 Q2 37,024,002 $338,468,507 -$1,662,517 $9.13 185
2023 Q1 37,256,479 $339,825,615 -$18,966,042 $9.11 193
2022 Q4 39,236,281 $372,465,195 -$28,191,938 $9.48 196
2022 Q3 42,615,647 $363,850,317 -$24,771,325 $8.52 188
2022 Q2 44,960,111 $505,291,365 -$16,489,168 $11.23 208
2022 Q1 46,235,945 $754,500,251 +$21,190,473 $16.32 188
2021 Q4 44,869,196 $796,663,278 +$12,544,415 $17.75 187
2021 Q3 43,655,556 $643,094,536 -$18,050,704 $14.70 169
2021 Q2 44,878,201 $662,749,086 +$60,474,953 $14.76 164
2021 Q1 41,162,254 $540,255,738 +$113,958,472 $13.11 175
2020 Q4 32,507,113 $424,706,439 +$5,247,951 $13.06 167
2020 Q3 32,085,321 $433,109,072 +$34,732,781 $13.50 161
2020 Q2 28,855,913 $327,010,588 +$28,770,949 $11.33 147
2020 Q1 26,510,818 $268,285,514 +$12,107,031 $10.12 153
2019 Q4 25,765,637 $341,040,437 +$100,906,933 $13.23 155
2019 Q3 17,940,594 $203,421,030 +$16,565,975 $11.40 124
2019 Q2 16,643,140 $174,331,506 -$4,292,040 $10.50 132
2019 Q1 17,443,284 $171,374,491 +$62,912,030 $9.82 129
2018 Q4 11,080,747 $98,557,020 +$16,517,045 $8.89 102
2018 Q3 9,145,438 $86,134,822 +$537,174 $9.42 91
2018 Q2 9,089,421 $80,540,388 +$7,774,363 $8.86 86
2018 Q1 8,169,794 $56,772,573 -$10,375,195 $6.95 88
2017 Q4 9,678,224 $79,356,883 -$2,405,239 $8.20 91
2017 Q3 8,870,944 $79,662,271 +$7,623,043 $8.98 81
2017 Q2 8,024,132 $71,730,846 +$7,336,495 $8.94 77
2017 Q1 7,201,469 $65,385,962 +$4,176,840 $9.08 63
2016 Q4 7,449,704 $66,459,355 +$4,748,812 $8.92 60
2016 Q3 6,821,430 $66,573,905 +$9,245,928 $9.76 56
2016 Q2 4,931,722 $49,833,470 +$49,833,470 $10.11 31